Biodexa Pharmaceuticals Plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BDRX research report →
About the company
Biodexa Pharmaceuticals Plc, a biopharmaceutical company in the clinical development stage, is dedicated to advancing a diverse portfolio of products. Founded in 2000 and headquartered in Cardiff, United Kingdom, the company was formerly known as Midatech Pharma plc until its rebranding in March 2023. Its research and development efforts are focused on addressing significant unmet medical needs, including familial adenomatous polyposis, non-muscle invasive bladder cancer, Type 1 diabetes, and a spectrum of rare or orphan brain cancers.
- CEO
- Stephen Anthony Stamp
- IPO
- 2015
- Employees
- 13
- HQ
- Cardiff, GB
Price Chart
- Market Cap
- $2.19M
- P/E
- -0.16
- P/S
- 0.00
- P/B
- 0.09
- EV/EBITDA
- 0.79
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -55.81%
- ROIC
- -71.94%
- Revenue
- $0 · 0.00%
- Net Income
- $-6,244,097 · -8.99%
- EPS
- $-400.00 · 89.21%
- Op Income
- $-8,268,734
- FCF YoY
- 58.60%
- 52W High
- $66.50
- 52W Low
- $2.45
- 50D MA
- $3.30
- 200D MA
- $14.12
- Beta
- 1.22
- Avg Volume
- 428.39K
Get TickerSpark's AI analysis on BDRX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | Parker Stephen Barry | other | 576 |
| Mar 18, 26 | Merchant Ann Louise | other | 288 |
| Mar 18, 26 | Stamp Stephen Anthony | other | 859 |
| Mar 18, 26 | Stamp Stephen Anthony | other | 1,500 |
| Mar 18, 26 | Stamp Stephen Anthony | other | 25,000 |
| Mar 18, 26 | Stamp Stephen Anthony | other | 15,000 |
| Mar 18, 26 | de Vries Simon | other | 288 |
| Mar 18, 26 | Powell Fiona Mary | other | 286 |
| Mar 18, 26 | Powell Fiona Mary | other | 7,500 |
| Mar 18, 26 | Powell Fiona Mary | other | 8,750 |
Our BDRX coverage
Recent articles, reports, and earnings notes.
No research on BDRX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BDRX report →Similar companies
Peers in the same neighborhood.